Clinical Trial Update: RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity [NA]

View source ↗

Summary

A randomized trial comparing orlistat and polyglucosamine for the management of overweight and obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Orlistat (orlistat)
• Polyglucosamine (polyglucosamine)

Snippet

Sponsor: Certmedica International GmbH | Conditions: Overweight, Obesity | NA | Status: COMPLETED